International Trade Bulletin - Volume 1, Issue 11
Client Alert | 1 min read | 08.11.06
Inside this issue:
- MULTILATERAL TRADE IN THE SPOTLIGHT
- EUROPE IN THE SPOTLIGHT
- WTO: USTR Does Not Have Authority To Instruct the U.S. Department of Commerce To Implement Measures To Comply With An Adverse WTO Dispute Settlement Report
- ANTI-DUMPING: The U.S. Department of Commerce's policy of “zeroing” in antidumping duty investigations and administrative reviews has come under repeated fire from U.S. trading partners
- CHINA: China Postpones Higher Tariffs on Imported Auto Parts To Address Potential WTO Case
- CHINA: U.S. Commerce Department Invites Comments on Its Controversial China Export Proposal
- SANCTIONS: U.S. Congress Approves Legislation Regarding Economic Sanctions Against Burma and Iran
- EXPORT CONTROLS: U.S. Bureau of Industry and Security (“BIS”) Actively Enforcing Deemed Exports
- CROWELL & MORING NEWS: Crowell & Moring Trade Team completes Report for the European Commission on the tools that should be made available to implement the upcoming revised EU Market Access Strategy
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
